![Mark Hensley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Hensley
Presidente presso
CALLIDITAS THERAPEUTICS AB
Patrimonio netto: 84 767 $ in data 31/07/2026
Profilo
Mark E.
Hensley is currently Chairman at Calliditas Therapeutics AB and Chief Operating Officer & Executive Vice President at Heron Therapeutics, Inc. starting in 2025.
Formerly, Mr. Hensley was Chief Commercial Officer at Veloxis Pharmaceuticals A from 2018 to 2021.
Education includes an undergraduate degree from the University of North Texas.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 06/08/2026 | 170.901 ( 0,09% ) | 84 767 $ | 31/07/2026 |
Posizioni attive di Mark Hensley
| Società | Posizione | Inizio |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Presidente | - |
| HERON THERAPEUTICS, INC. | Direttore operativo | 28/04/2025 |
Precedenti posizioni note di Mark Hensley
| Società | Posizione | Fine |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Corporate Officer/Principal | 01/01/2021 |
Formazione di Mark Hensley
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
42
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
University of North Texas
 University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calliditas Therapeutics AB
 Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
